Broker Watch

Blackmores reinvestment for growth to suppress near-term earnings: Goldman Sachs

Tue 08 Mar 22, 11:12am (AEST)
Vitamins drugs pills BKL Blackmores

Key Points

  • Blackmores is making a push to rebuild its brand and grow in new markets
  • Goldman believes higher reinvestment will drag on near-term earnings growth
  • The stock has been downgraded to a Sell with a $75.20 price target

Goldman Sachs expects muted earnings growth from Blackmores (ASX: BKL) in the near-term following higher reinvestment and a strategic reset under new management. 

The downgrade comes amid Goldman’s recent preference for retail and eCommerce stocks in an inflationary environment. This is under the premise that “strong end market demand should provide greater ability to pass on higher input costs.”

“Reinvestment to suppress near-term earnings”

“Blackmores is executing well against its strategic plan as evident in the 1H22 result,” the broker noted.

While Blackmores shares struggled for upside on the day of its half-year results, the company was able to show its return to sustainable, profitable growth.

Notable highlights from February reporting season include: 

  • Revenue of $346m, up 15%

  • Net profit of $20.8m, up 9.6%

  • Gross margin of 54.2%, up 2.3 percentage points

  • Interim dividend of 63 cents, up 117%

Looking ahead, Blackmores is doubling down on reinvestments to rebuild its brand in existing markets, launch into new markets and drive efficiencies throughout the business.

Management said that Group investments will be $10-15m higher in the second-half of the year compared to the first-half, which could easily erode the company’s bottom line. 

“This higher reinvestment flagged by the company will result in a subdued earnings environment over the medium term,” warned the broker. 

Goldman downgraded Blackmores to a Sell (from Neutral) with a $75.20 price target. 

This represents a downside of -1.4% compared to Tuesday’s open of $76.26.

Strategy on track 

Blackmores said the business is on-track to deliver $55m in annualised gross savings by FY23 as well as prioritising new product innovation and digital investments.

Goldman believes the company's suppressed near-term earnings will outweigh the strategic turnaround.

Upside drivers 

In terms of what might make the broker more positive on the stock, Goldman pointed out the following:

  • Stronger than expected demand from international markets such as Indonesia and India 

  • Elevated demand for immunity related products, which grew circa 25% year-on-year in the first-half

  • Recovery of daigou channel

  • Success of new product launches in Asia and China

Blackmores Ltd (ASX BKL) Share Price - Market Index
Blackmores 12-month price chart


Written By

Kerry Sun

Content Strategist

Kerry holds a Bachelor of Commerce from Monash University. He is an avid swing trader, focused on technical set ups and breakouts. Outside of writing and trading, Kerry is a big UFC fan, loves poker and training Muay Thai. Connect via LinkedIn or email.

Get the latest news and insights direct to your inbox

Subscribe free